LAURUSLABS

Laurus Labs Share Price

 

 

Invest in Laurus Labs with 3.25X leverage

Invest with MTF
Laurus Labs live price: ₹1008.8. It opened at ₹1,019 vs previous close ₹1,024; intraday high/low: ₹1,021/₹1,001. The 50 & 200 DMA stand at ₹1,011.74/₹918.99.

Laurus Labs Performance

  • Today's Low
  • ₹1,001
  • Today's High
  • ₹1,021
  • 52 Week Low
  • ₹518
  • 52 Week High
  • ₹1,141
  • Open Price₹1,019
  • Previous Close₹1,024
  • Volume6,517,137
  • 50 DMA₹1,011.74
  • 100 DMA₹993.31
  • 200 DMA₹918.99

Investment Returns

  • Over 1 Month -6.23%
  • Over 3 Month -7.02%
  • Over 6 Month + 21.21%
  • Over 1 Year + 64.46%

Smart Investing Starts Here Start SIP with Laurus Labs for Steady Growth!

Invest Now

Laurus Labs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 64.6
  • PEG Ratio
  • 0.2
  • Market Cap Cr
  • 54,461
  • P/B Ratio
  • 10.8
  • Average True Range
  • 36.97
  • EPS
  • 15.62
  • Dividend Yield
  • 0.2
  • MACD Signal
  • -8.4
  • RSI
  • 50.19
  • MFI
  • 31.74

Laurus Labs Financials

Laurus Labs Technicals

EMA & SMA

Current Price
₹1,008.80
-14.7 (-1.44%)
pointer
  • Bearish Moving Average 5
  • Bullish Moving Average 11
  • 20 Day
  • ₹1,004.34
  • 50 Day
  • ₹1,011.74
  • 100 Day
  • ₹993.31
  • 200 Day
  • ₹918.99

Resistance and Support

1010.1 Pivot Speed
  • R3 1,040.20
  • R2 1,030.60
  • R1 1,019.70
  • S1 999.20
  • S2 989.60
  • S3 978.70

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Laurus Labs Ltd. is a leading pharmaceutical company specializing in the development and manufacture of Active Pharmaceutical Ingredients (APIs), focusing on anti-retrovirals, oncology, and cardiovascular treatments. It also provides contract development and manufacturing (CDMO) services globally.

Laurus Labs has an operating revenue of Rs. 6,721.63 Cr. on a trailing 12-month basis. An annual revenue growth of 11% is good, Pre-tax margin of 9% is okay, ROE of 8% is fair but needs improvement. The company has a reasonable debt to equity of 14%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 10% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 10% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 77 which is a FAIR score but needs to improve its earnings, a RS Rating of 90 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 38 indicates it belongs to a strong industry group of Medical-Diversified and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Laurus Labs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-01-23 Quarterly Results
2025-10-23 Quarterly Results & Interim Dividend
2025-07-25 Quarterly Results
2025-04-24 Audited Results & Interim Dividend
2025-01-24 Quarterly Results
Date Purpose Remarks
2025-10-31 INTERIM Rs.0.80 per share(40%)Interim Dividend
2025-05-09 INTERIM Rs.0.80 per share(40%)Second Interim Dividend
2024-11-06 INTERIM Rs.0.40 per share(20%)Interim Dividend
2024-05-08 INTERIM Rs.0.40 per share(20%)Interim Dividend
2023-11-02 INTERIM Rs.0.40 per share(20%)Interim Dividend
View Laurus Labs Dividend History Arrow

Laurus Labs F&O

Laurus Labs Shareholding Pattern

27.49%
9.49%
1.52%
26.52%
0%
22.64%
12.34%

Laurus Labs FAQs

Laurus Labs share price is ₹1,008 As on 30 March, 2026 | 03:49

The Market Cap of Laurus Labs is ₹54460.7 Cr As on 30 March, 2026 | 03:49

The P/E ratio of Laurus Labs is 64.6 As on 30 March, 2026 | 03:49

The PB ratio of Laurus Labs is 10.8 As on 30 March, 2026 | 03:49

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23